Shlomo Noy
Director · Silexion Therapeutics Corp
- 2026
- Feb 25, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Shlomo Noy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mitchell Shirvan - $31K in SLXN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Shlomo Noy?
Shlomo Noy is a corporate insider, tracked as Director of Silexion Therapeutics Corp (SLXN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Shlomo Noy last file a Form 4?
The only primary Form 4 on record is dated 25 February 2026.